Marwan Fakih, Neil Howard Segal, Benjamin L. Schlechter, Thierry André, Filippo Pietrantonio, Benny Johnson, Alexander Vasilyev, Smitha S. Krishnamurthi, Salvatore Siena, Wells A. Messersmith, Virgilio Souza E Silva, Andrew Scott Paulson, Elena Elez, Cathy Eng, Sabine Tejpar, Michel Pierre Ducreux, Wei Wu, Joseph Elan Grossman, Eric Van Cutsem, Manuel Hidalgo. "Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.23